STR-P004 / Starna Therap - LARVOL DELTA

To Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of STR-P004 (clinicaltrials.gov) - P=N/A | N=11 | Not yet recruiting | Sponsor: Starna Therapeutics

New trial • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology

Exploratory Clinical Study on the Safety of STR-P004 in the Treatment of Patients With Relapsed or Refractory Autoimmune Diseases (clinicaltrials.gov) - P=N/A | N=39 | Not yet recruiting | Sponsor: Beijing GoBroad Hospital

New trial • Immunology

A Study to Evaluate the Safety and Clinical Efficacy of STR-P004 (clinicaltrials.gov) - P1 | N=30 | Not yet recruiting | Sponsor: Starna Therapeutics

New P1 trial • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology